Oncotarget

Research Papers:

Expression of HNF4G and its potential functions in lung cancer

Jingyu Wang, Jun Zhang, Longsheng Xu, Ying Zheng, Danyan Ling and Zhiping Yang _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2018; 9:18018-18028. https://doi.org/10.18632/oncotarget.22933

Metrics: PDF 1787 views  |   HTML 3020 views  |   ?  


Abstract

Jingyu Wang1, Jun Zhang2, Longsheng Xu3, Ying Zheng3, Danyan Ling4 and Zhiping Yang5

1Department of Pathology, The First Affiliated Hospital of Jiaxing University, Jiaxing, China

2Department of Chest Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, China

3Department of Central laboratory, The First Affiliated Hospital of Jiaxing University, Jiaxing, China

4Department of Cell Division, Shanghai Emay Biotechnologies Co., Ltd, Shanghai, China

5Department of Oncology (04-F-14), The First Affiliated Hospital of Jiaxing University, Jiaxing, China

Correspondence to:

Zhiping Yang, email: [email protected]

Keywords: HNF4G; AKT; lung cancer; proliferation; apoptosis

Received: July 20, 2017     Accepted: October 30, 2017     Epub: December 04, 2017     Published: April 06, 2018

ABSTRACT

The hepatocyte nuclear factor 4 gamma (HNF4G), a member of orphan nuclear receptors, is up-regulated and functions as an oncoprotein in bladder cancer. In the present study, we observed that HNF4G expression was elevated in lung cancer tissues as compared to adjacent normal lung tissues. The expression of HNF4G protein was correlated with the tumor size and the prognosis of patients. Transfection with a small interference RNA (siRNA) targeting HNF4G in two lung cancer cell lines (H358 and H292 cells) significantly inhibited cell proliferation via arresting cells at G1 phase and inducing cell apoptosis. In addition, HNF4G siRNA reduced cell proliferation in a xenograft tumor-bearing model. Moreover, A549 cells, which had relative lower level of HNF4G, were ectopic expressed with HNF4G and treated with an AKT inhibitor (MK-2206). MK-2206 exposure not only attenuated the promoting effects of HNF4G overexpression on cell proliferation and cell cycle progression, but also suppressed the inhibitory effects of HNF4G overexpression on cell apoptosis. These data suggested that AKT signaling pathway was a potential upstream mediator of HNF4G. Collectively, our data indicate that HNF4G exerts as an oncogenic role in lung cancer by promoting cell proliferation and that HNF4G expression is a potential prognosis factor for lung cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22933